Latest filing published 16 Jul 2026 for CYTOKINETICS INC, €20k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
John T. Henderson (board member) discloses dealings in Cytokinetics Inc to SEC (Form 4). In total, 38 filings cover trades dated from 1 April 2021 to 15 July 2026.
Sales make up the whole of the open-market record (1 sale, €635k). Besides market trades, the filings include 27 share grants and 10 option exercises.
The record was last updated on 16 July 2026 with a share grant (€20k) in Cytokinetics Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 38 declarations